1. Introduction {#s0005}
===============

The plant *Flueggea virosa* (Euphorbiaceae) also known as Chinese water berry, grow wild in tropical Africa, tropical Asia, Japan, Middle East, Australia and other parts of the world. Various organs of *F. virosa* are used to treat ailments such as arrhythmia, hepatitis, diabetes, HIV-related infections, fever, malaria, epilepsy. Several other biological effects of *F. virosa* include antiplasmodial, trypanocidal and antioxidant ([@b0080]). A wide range of chemical constituents include alkaloids, triterpenoids, resins, steroids, cardiac glycosides, bergenin, menisdaurin and anthraquinones have been reported in *F. virosa* ([@b0080])*.* Flavonoids, saponins ([@b0055]), 11-*O*-acetyl bergenin, virosecurinine, *ent*-phyllanthidine, kaempferol, quercetin, gallic acid, daucosterol and β-sitosterol ([@b0090]) are some other phytoconstituents reported in *F. virosa*.

(+)-Phyllanthidine or *ent*-phyllanthidine ([Fig. 1](#f0005){ref-type="fig"}) is a *Securinega* alkaloid (securinane-type) reported in few plants of family Euphorbiaceae (Phyllanthaceae) such as *Securinega*, *Phyllanthus*, *Margaritaria*, *Breynia*, *Flueggea*. *ent*-Phyllanthidine was first isolated from *Breynia coronata* though its enantiomer (−)-Phyllanthidine was isolated twenty years earlier to this from the plant *Phyllanthus discoides*. *ent*-Phyllanthidine possesses significant therapeutic potential against many ailments such as leishmaniasis and hepatitis B virus ([@b0065]).Figure 1Chemical structure of *ent*-phyllanthidine.

Rutin ([Fig. 2](#f0010){ref-type="fig"}) is an important flavonoid and almost an integral part of our daily diet. It is a vital constituent of many food items, vegetables, and beverages. Rutin possesses hepatoprotective, gastroprotective, anti-inflammatory and anti-diabetic effects ([@b0040]). Some other, biological activities of rutin include antitumor, anti-asthmatic, antioxidant and antimicrobial. Due to the tremendous therapeutic potential rutin is considered as one of the essential flavonoids in pharmaceutical industry ([@b0050]).Figure 2Chemical structure of rutin.

During last few decades, herbs and herbal products have largely been adapted as complementary and alternative medicines. Natural products have already been proved to be a potential source for the treatment of many diseases but usually lack scientific verification and data to support. Due to deficiency of scientific data the World Health Organization (WHO) has given the emphasis on scientific evaluation of the effectiveness of plant-based drugs ([@b0050]). Several methods reported the quantification of rutin, and these include HPTLC, RP-HPTLC ([@b0010]), HPLC-ED ([@b0020]), LC-MS/MS ([@b0015]), and electroanalytical methods ([@b0060]) in various samples of plant extracts, marketed formulations, and biological fluids, but no reporting was found regarding the estimation of *ent*-phyllanthidine along with rutin by chromatographic methods. Keeping in view a wide spectrum of biological activities and increasing demand for natural products this study was performed for concurrent analysis of rutin and *ent*-phyllanthidine in the methanol extract of *F. virosa*. This study was the first reporting of simultaneous quantification of above mentioned two biomarkers by a validated HPTLC method. The validation of developed method was done according to International Conference on Harmonization (ICH) guideline ([@b0045]).

2. Materials and methods {#s0010}
========================

2.1. Materials {#s0015}
--------------

The plant material (*F. virosa*) was collected during spring season from the southern part of Saudi Arabia and identified by Dr. Muhammad Yousaf, Department of Pharmacognosy, College of Pharmacy, King Saud University (KSU), Riyadh, Saudi Arabia (SA). A specimen voucher (Number 15745a) was preserved in the departmental herbarium, Department of Pharmacognosy, College of Pharmacy, KSU, Riyadh, SA.

2.2. Apparatus, reagents and reference standards {#s0020}
------------------------------------------------

Standards of rutin and *ent*-phyllanthidine were obtained from Sigma-Aldrich. Reagents and solvents of analytical grade were purchased from Fluka Chemicals (Busch, Switzerland) and Acros Organics (Hamilton, NJ), respectively. Pre-coated reverse phase HPTLC glass plates of silica gel 60 RP-18F~254~ were purchased (E. Merck, Germany). The standard and the extracts were applied to RP-HPTLC plates band wise with the help of CAMAG automatic TLC sampler-4 and developed in automatic development chamber-II. Scanning and documentation of developed RP-HPLTLC plate were done by CATS 4 and CAMAG TLC Reprostar 3, respectively.

2.3. Extraction conditions and preparation of sample {#s0025}
----------------------------------------------------

The extraction of *F. virosa* was done according to the method proposed for the estimation of rutin by [@b0010] in which the aerial parts of selected plant were dried in shade and coarsely powdered. 50 g of the powdered plant material was packed in a muslin fabric and extracted by Soxhletation using methanol (95%) as extractive solvent. The obtained extract (FVME) was concentrated by using rotary evaporator and finally dried. The percent yield of extract was found to be 9.14% *w*/*w.* The selection of an extractive solvent (methanol) was based on the solubility of marker compounds.

2.4. Preparation of reference standards {#s0030}
---------------------------------------

Methanol was used to prepare a stock solution of reference standards for *ent*-phyllanthidine and rutin (1 mg mL^−1^). To furnish the concentration of 100 μg mL^−1^, one milliliter of the stock solutions was again diluted to 9 mL each of methanol. For calibration, standard solution (2--16 μL) of *ent*-phyllanthidine and (1--14 μL) of rutin was applied on RP-HPTLC plate to keep the concentration in the range of 200--1600 ngband^−1^ and 100--1400 ngband^−1^, respectively.

2.5. HPTLC instrumentation and chromatographic conditions {#s0035}
---------------------------------------------------------

The quantitative analysis of *ent*-phyllanthidine and rutin was carried out on 20 × 10 cm RP-HPTLC plate. Automatic HPTLC Sampler 4 (ATS4) fitted with Hamilton Gastight Syringe (1700 Series) of volume 25 μL was used to apply the samples as well as standard on RP-HPTLC plate. The samples were applied to the plate at the rate of 160 nL/s. The plate was developed in previously saturated (saturation time 20 min at 25 °C with vapors of mobile phase) automatic developing chamber (ADC2) in linear ascending mode with acetonitrile: water (4:6 *V*/*V*) used as mobile phase. After development, the plate was dried at room temperature and derivatized with freshly prepared Dragendorff reagent for detection of *ent*-phyllanthidine, scanned, and quantified at 310 nm wavelength in absorbance mode with CATS 4 operated by WinCATS software (Version 1.2.0).

2.6. Preparation of calibration graph {#s0040}
-------------------------------------

A series of spots of different volumes were applied to prepare the calibration graph of *ent*-phyllanthidine and rutin. Different volumes of spots have provided a different concentrations of biomarkers per spot for making calibration graph. Area and height versus quantity per spot were taken into consideration for preparing the calibration graph.

2.7. Method development {#s0045}
-----------------------

After trying several combinations of mobile phase and its optimization, the chromatogram was developed. The selected mobile phase \[ACN: H~2~O (4:6 *V*/*V*)\] provides the best resolution. The same mobile phase ([Fig. 3](#f0015){ref-type="fig"}) has been employed for the separation of methanol extracts of the sample (FVME) applied as three bands of 2, 3 and 4 μL volume. The optimized saturation time was observed as 20 min. The analysis was done densitometrically at absorption maxima of wavelength 310 nm in absorbance mode.Figure 3Picture of developed RP-HPTLC plate at 254 nm wavelength.

2.8. Method validation {#s0050}
----------------------

As per ICH guidelines the parameters such as linearity range, precision, accuracy, robustness, recovery, limit of detection (LOD) and limit of quantification (LOQ) have been considered for the validation of the proposed method. Replicate analyses (*n* = 6) of samples at three quality control (QC) levels have been performed to evaluate accuracy and precision. These three QC levels were low, medium and high with a concentration of 200, 400 and 600 ngband^−1^, respectively for *ent*-phyllanthidine and 150, 300 and 600 ngband^−1^, respectively for rutin.

The intraday assay was repeated for three different days to determine the inter-day precision and accuracy. Percentage of the coefficient of variation (% CV) of measured concentration for each calibration level was used to express precision while percentage recovery was used to express accuracy. The robustness of the proposed method was evaluated in triplicate at 300 ngband^−1^ by introducing some deliberate changes to the volume of mobile phase, the composition of mobile phase and duration of saturation. The results were evaluated in terms of relative standard deviation (RSD %) and standard error of peak areas. The mobile phases prepared from acetonitrile: water (4:6, *V*/*V*) in different proportions (4.5:5.5, *V*/*V*; 3.5:6.5, *V*/*V*; 4.25:5.75, *V*/*V*) were used for chromatography. The duration of saturation and mobile phase volume investigated was 20 ± 10 min (10, 20 and 30 min) and 20 ± 2 mL (18, 20 and 22 mL), respectively.

The calculation of LOD and LOQ was made on the basis of standard deviation (SD) of the response and the slope (s) of the calibration graph using formulae \[LOD = 3.3 (SD/S) and LOQ = 10 (SD/S)\]. The study of recovery was made by applying the method to drug samples to which known quantity of the marker corresponding to 50%, 100% and 150% of the *ent*-phyllanthidine and rutin had been added. The analysis of each level was made in triplicate. The utility of this method was exploited to check the recovery of *ent*-phyllanthidine and rutin at different levels in the extracts.

3. Results and discussion {#s0055}
=========================

3.1. Method development and validation {#s0060}
--------------------------------------

The selected mobile phase \[ACN: H~2~O (4:6 *V*/*V*)\] gives compact, symmetrical, sharp and high-resolution bands of *ent*-phyllanthidine (FV1) and rutin (FV2) at *R~f~* 0.73 ± 0.01 and 0.68 ± 0.01, respectively ([Fig. 3](#f0015){ref-type="fig"}). The suggested method was found to be specific with excellent baseline resolution ([Fig. 4](#f0020){ref-type="fig"}). The outcome of this experiment can be recommended as a maiden method for simultaneous quantification of *ent*-phyllanthidine and rutin in *F. virosa* as well as in herbs and herbal formulations containing *ent*-phyllanthidine and rutin together by a cost effective, simple and sensitive RP-HPTLC method.Figure 4Chromatogram of standards FV1 (*ent*-phyllanthidine; 1600 ng/spot) and FV2 (Rutin; 1400 ng/spot) at 310 nm wavelength; mobile phase: ACN: H~2~O (4:6 **V*/*V**) in RP-HPTLC.

3.2. RP-HPTLC study of FVME {#s0065}
---------------------------

The proposed method was utilized for the quantitation of *ent*-phyllanthidine and rutin in FVME ([Fig. 5](#f0025){ref-type="fig"}). Three volumes 2, 3 and 4 μL of FVME were applied on RP-HPTLC plate for quantitative analysis. The bands of *ent*-phyllanthidine and rutin in sample extract (FVME) were confirmed by the 3D display of all tracks of standards as well as a sample ([Fig. 6](#f0030){ref-type="fig"}). The concentration of *ent*-phyllanthidine and rutin in the FVME was found to be 9.121 ± 0.02 and 1.018 ± 0.04% (w/w), respectively. This is the maiden method developed for concurrent estimation of biomarkers *ent*-phyllanthidine and rutin in *F. virosa* collected from Saudi Arabia.Figure 5Chromatogram of FVME (2 μL) \[*ent*-phyllanthidine (FV1), *R~f~* = 0.73 and Rutin (FV2), *R~f~* = 0.68\] at 310 nm wavelength; mobile phase: ACN: H~2~O (4:6 *V*/*V*) in RP-HPTLC.Figure 63D-display of all tracks \@310 nm developed on RP-HPTLC plate; mobile phase: ACN: H~2~O (4:6 *V*/*V*).

3.3. Method validation {#s0070}
----------------------

Linear regression and correlation coefficient were used for validation of linearity for the biomarkers *ent*-phyllanthidine and rutin. The calibration graph was made with eight concentrations of *ent*-phyllanthidine and rutin and showed the good linear relationship in the range of 200--1600 ngband^−1^ and 100--1400 ngband^−1^, respectively. The linear regression equations and *r*^2^ values for the standard reference *ent*-phyllanthidine and rutin were observed as *Y* = 2.722*x* + 209.141 & 0.998 and *Y* = 3.567*x* + 316.119 & 0.997, respectively, which revealed a significant linearity response for developed method ([Table 1](#t0005){ref-type="table"}). The mean value with ± SD of the slope and intercept was 2.722 ± 0.003 and 209.141 ± 0.011 for *ent*-phyllanthidine and 3.567 ± 0.002 and 316.119 ± 0.013 for rutin. No substantial difference was detected on the slopes of standard plots (*P* \> 0.05). [Table 2](#t0010){ref-type="table"} presents intra- and interday precision and accuracy of the assay for *ent*-phyllanthidine and rutin at triplicate QC levels (200, 400 and 600 ngband^−1^ and 150, 300 and 600 ngband^−1^), respectively. Both intra- and interday precisions were determined regarding percent of coefficient of variation (% CV). Intra- and interday precisions (*n* = 6) for *ent*-phyllanthidine and rutin were found to be in the range of 1.31--1.84% and 1.37--1.85%, and 1.24--1.61% and 1.45--1.80%, respectively, which demonstrated the good precision of proposed method. However, the intra- and interday accuracies of *ent*-phyllanthidine and rutin were observed as 98.5--99.5% and 98.3--98.7% and 98.1--99.6% and 97.4--99.4%, respectively. These results indicated the accuracy of the proposed method. In [Table 3](#t0015){ref-type="table"}, the SD and % RSD were calculated at 300 ngband^−1^ concentration level of *ent*-phyllanthidine and rutin. The robustness of the proposed method was depicted by the low values of SD and % RSD obtained after putting into small deliberate changes in the optimized method. LOD/LOQ for *ent*-phyllanthidine and rutin were observed as 48/145 ngband^−1^ and 39/117 ngband^−1^, respectively ([Table 1](#t0005){ref-type="table"}). The observations for robustness indicated that the proposed method exhibited an excellent sensitivity for the quantification of above compounds. After spiking good recoveries were observed at three QC levels of *ent*-phyllanthidine and rutin. As shown in [Table 4](#t0020){ref-type="table"}, after sample treatment and application excellent recoveries for *ent*-phyllanthidine (98.4--99.6%) and rutin (99.3--99.7%) were witnessed.Table 1*R~f~*, linear regression data for the calibration curve and sensitivity parameter for *ent*-phyllanthidine (FV1) and rutin (FV2).Parameter*ent*-PhyllanthidineRutin*R~f~*0.73 ± 0.010.68 ± 0.01Linearity range (ngband^−1^)200--1600100--1400Regression equation*Y* = 2.722*x* + 209.141*Y* = 3.567*x* + 316.119Correlation coefficient (*r*^2^)0.9980.997Slope ± SD2.722 + 0.0033.567 ± 0.002Intercept ± SD209.141 + 0.011316.119 ± 0.013Standard error of slope0.0030.002Standard error of intercept0.0110.013LOD48 ngband^−1^39 ngband^−1^LOQ145 ngband^−1^117 ngband^−1^Table 2Precision and accuracy of *ent*-phyllanthidine (FV1) and rutin (FV2).Marker compoundNominal concentration (a)Concentration obtained ± SD (b)Precision (c) (CV, %)Accuracy (d)*Intraday batch*FV1200197.0 ± 3.621.8498.5400395.8 ± 5.701.4498.9600596.9 ± 7.831.3199.5FV2150147.2 ± 2.371.6198.1300296.5 ± 4.111.3998.8600597.8 ± 7.431.2499.6  *Interday batch*FV1200196.6 ± 3.651.8598.3400394.8 ± 6.531.6598.7600591.3 ± 8.151.3798.5FV2150146.1 ± 2.121.4597.4300294.3 ± 5.321.8098.1600596.1 ± 10.471.7599.4[^1]Table 3Robustness of the method.Optimization condition*ent*-PhyllanthidineRutinSD% RSDSD% RSD*Mobile phase from acetonitrile: water (4:6 *V*/*V*)*(4.5:5.5, *V*/*V*; 3.5:6.5, *V*/*V*; 4.25:5.75, *V*/*V*)6.460.0276.430.021Mobile phase volume (18, 20 and 22 mL)5.610.0195.060.018Duration of saturation (10, 20 and 30 min)3.310.0124.180.015Table 4Recovery studies of *ent*-phyllanthidine (FV1) and rutin (FV2).Marker compoundConcentration added to analyte (%)Theoretical quantity (ng)Added quantity (ng)Detected quantity (ng) ± SDRecovery (%)RSD (%)*ent*-Phyllanthidine(FV1)30050450443.1 ± 8.1298.41.83100600593.8 ± 6.1998.91.04150750746.7 ± 7.8699.61.05  Rutin (FV2)30050450446.9 ± 6.3199.31.41100600597.1 ± 6.2199.51.04150750748.11 ± 8.7899.71.17

According to the available literature, *ent*-phyllanthidine seems to be a very promising compound for the treatment of liver diseases and leishmaniasis. Along with the development of a method for quantification, the findings of this experiment also revealed that *Flueggea virosa* is a rich source of *ent*-phyllanthidine (9.121 ± 0.02%w/w). The presence of *ent*-phyllanthidine in such a substantial percentage justifies the use of *F. virosa* as folkloric medicine for the treatment of hepatitis ([@b0030]). Natural products especially functional food appear to be good alternatives for making the life easy and healthy. Some examples of fruits and vegetables are proved to be a rich source of a bioflavonoid rutin. Bioflavonoids possess a broad spectrum of biological activities. Rutin is a very common component of many fruits and vegetables. A wide spectrum of physiological and pharmacological activities of rutin in mammals either *in vivo* or *in vitro* has been scientifically proved ([@b0050]). It is reported that more than 100 registered medicinal preparations contain rutin in their formulations ([@b0050]). Due to awesome scavenging potential rutin is considered as potent anti-oxidant ([@b0025], [@b0070], [@b0005]). Being excellent anti-oxidant rutin acts as anti-inflammatory ([@b0035]), anti-tumor ([@b0075]), anti-microbial and anti-asthmatic agent ([@b0050]).

In many of the cases, the results of succeeding clinical trials of formulations do not show coherence with the previous results which may be due to the nonuniform process of extraction, the usage of different species, climatic variations and the differences at the site of harvest, which may directly affect the quantity of active constituents in the extract ([@b0085]). The proposed HPTLC method may provide a reliable tool for monitoring and production of standardized extracts, effective herbal formulations as well as accurate grading of crude drugs based on the levels of concentration of *ent*-phyllanthidine and rutin.

4. Conclusion {#s0075}
=============

The experimental findings suggested a simple and sensitive method for the simultaneous detection and quantification of *ent*-phyllanthidine and rutin in *F. virosa*. It is revealed from this study that *F. virosa* is an excellent source of *ent*-phyllanthidine which supports its traditional use in liver diseases and can also be recommended to treat leishmaniasis.
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[^1]: a: Concentration in ngband^−1^; b: Mean from six determinations (*n* = 6), c: Precision as coefficient of variation (CV, %) = \[(standard deviation)/(concentration found)\] × 100, d: Accuracy (%) = \[(concentration found)/(nominal concentration)\] × 100.
